Company / Financials
MARAVAI LIFESCIENCES HOLDINGS, INC. Financials
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$185.7M
FY2025 · -28.3% YoY
Net Income
-$130.8M
FY2025 · +9.7% YoY
Profit Margin
-70.4%
FY2025 · net income / revenue
ROE
-61.6%
FY2025 · return on equity
Total Assets
$770.6M
FY2025
Total Debt
$291.8M
1.37x debt/equity
Equity
$212.4M
FY2025
ROA
-17.0%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$185.7M-28.3% YoYNet Income HistoryProfit after all expenses and taxes-$130.8M+9.7% YoYGross Profit HistoryRevenue minus cost of goods sold$34.0M-68.6% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$151.8M+0.6% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$215.3M+8.6% YoYSG&A Expense HistorySelling, general, and administrative expenses$145.1M-10.3% YoYR&D Expense HistoryResearch and development spending$17.4M-9.5% YoYInterest Expense HistoryCost of borrowing and debt obligations$45.9MIncome Tax HistoryTotal income tax expense-$4.2M-126.5% YoYEPS (Basic) HistoryBasic earnings per share-$0.90-153.9% YoY